Wall Street Zen downgraded shares of Stem (NYSE:STEM – Free Report) from a hold rating to a sell rating in a report released on Saturday.
Separately, Weiss Ratings downgraded shares of Stem from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, February 11th. Three research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $20.00.
View Our Latest Report on Stem
Stem Stock Performance
Stem (NYSE:STEM – Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported ($1.85) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.96) by $0.11. The firm had revenue of $47.14 million during the quarter, compared to analysts’ expectations of $39.05 million. On average, analysts predict that Stem will post -0.52 EPS for the current fiscal year.
Hedge Funds Weigh In On Stem
A number of institutional investors have recently made changes to their positions in the stock. IFP Advisors Inc lifted its position in shares of Stem by 258.1% in the third quarter. IFP Advisors Inc now owns 1,479 shares of the company’s stock valued at $26,000 after acquiring an additional 1,066 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in Stem during the 4th quarter worth about $29,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in Stem during the 3rd quarter worth about $55,000. Bridgeway Capital Management LLC acquired a new position in Stem in the 2nd quarter valued at about $97,000. Finally, Zweig DiMenna Associates LLC acquired a new position in Stem in the 4th quarter valued at about $125,000. 61.63% of the stock is owned by institutional investors and hedge funds.
More Stem News
Here are the key news stories impacting Stem this week:
- Neutral Sentiment: Article comparing Stem, Inc. with Clarivate provides a mixed peer/valuation look but contains no new operational news for Stem, so limited near-term impact. Comparing Stem (NYSE:STEM) and Clarivate (NYSE:CLVT)
- Neutral Sentiment: Pharmaphorum piece on “STEM AI” discusses data-led field team performance in pharma — not related to Stem, Inc.’s energy-storage business, so unlikely to move the stock. STEM AI: A new lens on data-led field team performance
- Neutral Sentiment: Multiple local education stories (MiSTEM grants, new STEM classrooms, student showcases) reflect increased activity in K–12 STEM programs but are unlikely to affect Stem, Inc.’s near-term revenue or contracts. Examples: Cadillac/Charlevoix MiSTEM grants; Sherwood Elementary STEM classroom; Edwardsville science fair. Cadillac, Charlevoix among schools to recieve MiSTEM grant funds for hands-on STEM learning
- Neutral Sentiment: Coverage of stem-cell therapy approvals and treatments (Japan approval, ScienceAlert on approvals for Parkinson’s and heart failure) are medically focused and unrelated to Stem, Inc.; they may cause name-based confusion but not a direct business impact. Stem Cell Treatments For Parkinson’s And Heart Failure Approved in World First
- Neutral Sentiment: Other community/academic items (Rutgers scholarship, Ed.D. dissertation defense) are local STEM ecosystem news without material relevance to Stem, Inc.’s financials. Rutgers Student Receives SBB Research Group Foundation STEM Scholarship
About Stem
Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.
At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.
Further Reading
- Five stocks we like better than Stem
- Gold Shock Coming March 18?
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
